T18661 |
(S,R,S)-AHPC-C10-NH2 dihydrochloride
|
2341796-75-4
|
98%
|
|
(S,R,S)-AHPC-C10-NH2 dihydrochloride (VH032-linker 10) is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a l...
|
T18822 |
Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride
|
2245697-85-0
|
98%
|
|
Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the Thalidomide-based cereblon ligand and a linker...
|
T17913 |
(S,R,S)-AHPC-PEG2-N3
|
2010159-45-0
|
98%
|
|
(S,R,S)-AHPC-PEG2-N3 (VHL Ligand-Linker Conjugates 6) is a synthesized E3 ligase ligand-linker conjugate containing a (S,R,S)-AHPC based VHL ligand and 2 unit PE...
|
T9360 |
CRBN ligand-9
|
55003-81-1
|
99.88%
|
|
CRBN ligand-9 (2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline-1,3-dione) exhibit inhibition of CRBN.
|
T7752 |
(S,R,S)-AHPC-Me
|
1948273-02-6
|
99.86%
|
|
(S,R,S)-AHPC-Me (E3 ligase Ligand 1A) (VHL ligand 2) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein[1]. (S,R...
|
T5334 |
VL285
|
1448188-57-5
|
99.85%
|
|
VL285 is a potent VHL ligand, degrading HaloTag7 fusion proteins.
|
T7758 |
Thalidomide-O-amido-PEG3-C2-NH2 TFA
|
1957236-21-3
|
99.82%
|
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG3-C2-N...
|
T18066 |
Lenalidomide-OH
|
1416990-08-3
|
99.77%
|
|
Lenalidomide-OH is a ligand of cereblon (CRBN), serving as an analog to Lenalidomide for E3 ubiquitin ligase. It is utilized in the recruitment of CRBN protein. ...
|
T29106 |
VH032
|
1448188-62-2
|
99.72%
|
|
VH032 commonly used as a precursor to a PROTAC that hijacks VHL as the E3 ubiquitin ligase component.VH032 is a VHL/HIF-1α interaction inhibitor with a KdPROTACs...
|
T7761 |
Pomalidomide-C2-NH2 hydrochloride
|
2305369-00-8
|
99.66%
|
|
Pomalidomide-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate. Pomalidomide-C2-NH2 hydrochloride incorporates the Pomalidomide based cereb...
|
T7763 |
Thalidomide-4-OH
|
5054-59-1
|
99.59%
|
|
Thalidomide-4-OH (E3 ligase Ligand 2) (Cereblon ligand 2) is the Thalidomide-based Cereblon ligand used to recruit of CRBN protein. Thalidomide-4-OH (Cereblon li...
|
T1642 |
Lenalidomide
|
191732-72-6
|
99.5%
|
|
Lenalidomide (CC-5013) is a potent inhibitor of TNF-α that, at 10 μM, alters gene expression and cell viability in a range of cancer cell lines.
|
T7756 |
Pomalidomide-PEG4-Ph-NH2
|
1818885-63-0
|
99.49%
|
|
Pomalidomide-PEG4-Ph-NH2 is a synthetic E3 ligase ligand-linker conjugate combining a Pomalidomide-based cereblon ligand and a 4-unit PEG linker.
|
T10765 |
Eragidomide
|
1860875-51-9
|
99.41%
|
|
Eragidomide (CC-90009; Cereblon modulator 1) is a cereblon (CRBN) E3 ligase modulator. Eragidomide specifically binds to CRBN, thereby affecting the activity of ...
|
T40028 |
(S,R,S)-AHPC
|
2055344-67-5
|
99.40%
|
|
(S,R,S)-AHPC is a VHL ligand that used in the recruitment of the VHL protein.
|
T18787 |
TD-165
|
2305936-56-3
|
99.24%
|
|
TD-165, a PROTAC-based cereblon (CRBN) degrader, consists of a cereblon (CRBN) ligand-binding group, a linker, and a von Hippel-Landau (VHL) binding group[1].
|
T8824 |
CRBN modulator-1
|
2407829-65-4
|
99.24%
|
|
CRBN modulator-1 (WUN29654) is a Thalidomide analog and CRBN modulator,has an IC50 of 3.5 μM and a Ki of 0.98 μM.
|
T7755 |
Thalidomide 4-fluoride
|
835616-60-9
|
99.12%
|
|
Thalidomide 4-fluoride (E3 ligase Ligand 4) (Cereblon ligand 4) is the Thalidomide-based Cereblon ligand. Thalidomide 4-fluoride can be used in the recruitment o...
|
T9117 |
BSJ-4-116
|
2519823-34-6
|
99.09%
|
|
BSJ-4-116 is a highly potent and selective CDK12 degrader (PROTAC) with an IC50 of 6 nM. It downregulates DDR genes through a premature termination of transcript...
|
T14893 |
CC-885
|
1010100-07-8
|
99.08%
|
|
CC-885 is a modulator of cereblon (CRBN). It has potent anti-tumour activity.
|